611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Coronavirus Deaths in Nursing Homes Climbing AgainGet Dizzy When Standing Up? It Could Be Risk Factor for DementiaLevels of Anxiety, Addiction, Suicidal Thoughts Are Soaring in the PandemicWhat Was More Deadly for New Yorkers – COVID-19 or the 1918 Flu?Sweden's No-Lockdown Policy Didn't Achieve 'Herd Immunity'U.S. Coronavirus Death Tally Hits New High for SummerPfizer's COVID Vaccine Shows 'Robust' Results in Early TrialFrequent COVID Tests Key to College Reopening: ExpertsMany Community Outbreaks of COVID Traced to Restaurants, BarsPut the Brakes on Driving After a ConcussionStrict, Costly Measures Needed to Reopen Schools: StudyCOVID-19 Risk Up to 7 Times Higher for Young VapersAnother COVID Hazard: False InformationHospitals Full, Doctors Treated Her Severe COVID-19 at HomeFDA Approves First Oral Drug for Spinal Muscular AtrophyCOVID-19 Fears Stop Americans From Seeking Help for Heart EmergenciesAHA News: What Do Heart Patients Need to Know About COVID-19 Now?Have Diabetes? Don't Lose Sight of Danger to Your EyesBlood Test Might Spot Most Dangerous COVID-19 CasesAs Schools Reopen, Report Shows 97,000 U.S. Kids Infected With COVID in Late JulyWhat Parents Need to Know About Teens and ConcussionsBaby's Meningitis Case Highlights Growing Danger of Antibiotic ResistanceAs in Adults, Minority Kids Hit Hardest by COVID-19Simple Test Shows Which Face Masks Are BestBeware of Hand Sanitizers Containing MethanolWhat Athletes Should Know About COVID-19, Heart Damage and Working OutCOVID-19 Causing More Stress in America Than Other Nations: SurveyWill Your Kid Play School Sports This Fall? Here's Some Guidance on Doing It SafelyScientists Call for Broader Use of Faster COVID TestsTwo Common Nutrients Might Keep Vertigo at BayPeople Are Dying, Going Blind After Drinking Hand Sanitizer, CDC WarnsMore Social Media Use, More Fake COVID NewsSkip the 'Maskne,' Not the MaskObesity Ups Odds for Severe COVID-19, But Age MattersSeven States Join Pact to Speed Coronavirus TestingStudy Casts Doubt on Value of Cholesterol DrugsCOVID-19 Fears Had Sick, Injured Americans Avoiding ERsCancer Diagnoses Plunge as Americans Avoid Screening During PandemicMysterious Paralyzing Illness in Kids Is Set to Return, CDC WarnsMany Older Americans Staying Strong in the PandemicCoronavirus Cases Now Climbing in the MidwestCould the First Drug That Slows Arthritis Be Here?Schools Can Reopen Safely If Precautions in Place, Australian Study ShowsFace Masks, Yes, But Don't Forget Hand-Washing TooEven With PPE, Risk of COVID-19 Still High for Frontline WorkersCoronavirus Pandemic Becoming Far More Widespread, Birx SaysGuard Against Lyme Disease This SummerKids 'Efficient' Transmitters as COVID-19 Raced Through a Georgia Summer CampCollege Students Will Need COVID Tests Every 2-3 Days for Campus Safety: StudyAHA News: Sustained High Blood Pressure May Damage Brain Vessels
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

COVID-19 May Force Some Cancer Patients to Delay Treatment

HealthDay News
by By E.J. Mundell
HealthDay Reporter
Updated: Mar 25th 2020

new article illustration

WEDNESDAY, March 25, 2020 (HealthDay News) -- Early findings involving cancer patients from Wuhan, China -- the original epicenter of the COVID-19 pandemic -- suggest that many contracted the coronavirus while undergoing treatment in the hospital.

That could mean that this vulnerable population might need to discuss delaying cancer care to help minimize their odds of infection, the study authors said.

"We propose that aggressive measures be undertaken to reduce frequency of hospital visits of patients with cancer during a viral epidemic going forward," wrote a team led by Dr. Conghua Xie, of the department of radiation and medical oncology at Zhongnan Hospital of Wuhan University.

The research, which focused on 12 cancer patients treated at the hospital in January and February, was published March 25 in the journal JAMA Oncology.

It's long been understood that cancer, as well as its therapies, have the unfortunate side effect of weakening a patient's immune system. That can leave a patient more vulnerable to infectious illness, including COVID-19.

In the new study, Xie's team tracked infection incidence among more than 1,500 patients with cancer admitted to Zhongnan Hospital.

Twelve of those patients were later diagnosed with COVID-19, and the infection rate of the cancer patients was more than double that of the general population of Wuhan.

That's probably because people with cancer are often "immunocompromised," Xie's group wrote, and many may contract the new coronavirus during visits to the hospital for cancer care.

As seen in the general population, the risk of developing COVID-19 among cancer patients tended to rise with age: eight of 12 patients were over 60. Seven patients had lung cancer.

Three of the patients -- two with lung cancer, another with pancreatic cancer -- went on to develop severe COVID-19 requiring ICU care. All three died.

Of the remaining nine patients, six have recovered and have been discharged from the hospital, the team said.

According to the researchers, the take-home message from this small, early study is that during the COVID-19 pandemic, decisions may need to be made on curtailing cancer care. And if patients do require in-hospital treatment, "proper isolation protocols must be in place to mitigate the risk of [viral] infection," they said.

Three cancer specialists in the United States who reviewed the report agreed that cancer treatment may require patient-doctor discussions at this time.

Amy Moore directs science and research at the GO2 Foundation for Lung Cancer in Washington, D.C. She believes that lung cancer patients, especially, "may have elevated risk [of coronavirus infection] compared to other cancer types."

Also, Moore said, "hospital admissions and recurrent visits increase risk, reinforcing the importance of patients talking to their physicians regarding their own personal treatment plan."

Dr. Wasif Saif is medical director at the Northwell Health Cancer Institute in Lake Success, N.Y. He stressed that the study population was very small, so the findings must be considered preliminary. But certain patterns emerged.

"Cancer patients were deemed to be at highest risk for severe complications, including admission to the intensive care unit requiring invasive ventilation, or death," Saif noted. "Additionally, diagnosis of cancer was associated with a shorter time to development of severe events when compared to non-cancer patients."

Because hospitals are especially potent venues for coronavirus infection, Saif believes that "tough decisions have to be made during this COVID-19 crisis whether to delay [cancer] treatment or simplify the treatment."

But Dr. Adil Akhtar, director of inpatient clinical operations at Karmanos Cancer Institute at McLaren Oakland in Pontiac, Mich., took a slightly different view.

He agreed that cancer patients appear to be at higher odds of coronavirus infection, but added that "cancer programs across the U.S. have already implemented robust infection and environmental controls, as per the [U.S. Centers for Disease Control and Prevention] guidelines."

Akhtar added that, as per guidelines from the American Society of Clinical Oncology, at this time "there is no direct evidence to support changing or withholding chemotherapy or immunotherapy in patients with cancer."

He believes it's tough to determine, on an individual patient basis, whether the risk of contracting COVID-19 outweighs the benefit to be gained from continued cancer care.

So "clinical decisions should be individualized that consider factors such as the risk of cancer recurrence if therapy is delayed, modified or interrupted; the number of cycles of therapy already completed, and the patient's tolerance of treatment," Akhtar said.

More information

The U.S. Centers for Disease Control and Prevention has more on the new coronavirus.